COMPASS FINANCIAL MANAGEMENT LLC’s Oruka Therapeutics ORKA Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.73K	Buy	+38	New	+$2.53K	﹤0.01%	1238

Other funds holding ORKA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's ORKA Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 38 shares worth $3.73K. The stake represents ﹤0.01% of the portfolio and ranks #1238 among its holdings.

136 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

COMPASS FINANCIAL MANAGEMENT LLC held 38 shares of Oruka Therapeutics worth $3.73K as of Q2 2026.
Oruka Therapeutics was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
Oruka Therapeutics made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #1238 holding.
136 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.